Insider Buying: athenahealth, Inc (ATHN) Director Purchases 7,200 Shares of Stock

athenahealth, Inc (NASDAQ:ATHN) Director Jeffrey R. Immelt purchased 7,200 shares of the stock in a transaction dated Tuesday, February 20th. The shares were bought at an average price of $138.44 per share, for a total transaction of $996,768.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of athenahealth, Inc (ATHN) traded up $1.40 during trading hours on Wednesday, reaching $136.87. 211,033 shares of the company were exchanged, compared to its average volume of 606,332. The company has a market capitalization of $5,480.00, a PE ratio of 110.38, a PEG ratio of 2.93 and a beta of 1.35. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.84 and a quick ratio of 1.84. athenahealth, Inc has a 12-month low of $95.01 and a 12-month high of $158.66.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.48. The firm had revenue of $329.20 million during the quarter, compared to analyst estimates of $319.64 million. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The business’s revenue was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.62 EPS. equities analysts anticipate that athenahealth, Inc will post 2.29 earnings per share for the current year.

Several research firms have recently commented on ATHN. Piper Jaffray Companies restated a “buy” rating and set a $160.00 price target on shares of athenahealth in a report on Friday, February 16th. BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday. Royal Bank of Canada set a $141.00 price target on shares of athenahealth and gave the company a “hold” rating in a report on Thursday, February 15th. SunTrust Banks boosted their price target on shares of athenahealth to $180.00 and gave the company a “buy” rating in a report on Monday, February 5th. Finally, Canaccord Genuity boosted their price target on shares of athenahealth from $123.00 to $137.00 and gave the company a “hold” rating in a report on Thursday, February 1st. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $144.23.

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. lifted its position in athenahealth by 1.4% during the 4th quarter. BlackRock Inc. now owns 1,661,698 shares of the health services provider’s stock worth $221,073,000 after acquiring an additional 22,767 shares during the last quarter. Allianz Asset Management GmbH lifted its position in athenahealth by 67.0% during the 4th quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock worth $73,939,000 after acquiring an additional 223,006 shares during the last quarter. Jackson Square Partners LLC lifted its position in athenahealth by 1.1% during the 4th quarter. Jackson Square Partners LLC now owns 531,549 shares of the health services provider’s stock worth $70,717,000 after acquiring an additional 5,811 shares during the last quarter. State Street Corp lifted its position in athenahealth by 2.0% during the 2nd quarter. State Street Corp now owns 512,675 shares of the health services provider’s stock worth $72,052,000 after acquiring an additional 9,852 shares during the last quarter. Finally, ArrowMark Colorado Holdings LLC lifted its position in athenahealth by 30.1% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock worth $68,098,000 after acquiring an additional 118,411 shares during the last quarter.

TRADEMARK VIOLATION WARNING: This piece was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/21/insider-buying-athenahealth-inc-athn-director-purchases-7200-shares-of-stock.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply